XII Jornada Mineira de Radiologia
1º Dia - 6/19/26
2º Dia - 6/20/26

Discussão multidisciplinar: terapias combinadas Voltar

Stella Sala, Hugo Marçal, Pedro Henrique Furst Leite, Volney Soares

Curso: Medicina Nuclear - Sessão 7 - Próstata: Terapia com radioligantes - Denise Rodrigues e Pedro Henrique Furst Leite

Artigo Autor(es) Referência
Best Patient Care Practices for Administering PSMA-Targeted Radiopharmaceutical Therapy. Calais Jeremie, Morris Michael J, Kendi Ayse Tuba, Kalebasty Arash Rezazadeh, Tutrone Ronald, Anderson Michael J, Sartor Oliver Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2024 Nov; 65(Nov):1666-1671. doi: 10.2967/jnumed.124.268363. pii: .
Combination Therapy in Metastatic Hormone-Sensitive Prostate Cancer-Are We Moving Fast Enough? Barata Pedro C, Garcia Jorge A JAMA network open. 2025 May; 8(May):e259442. doi: 10.1001/jamanetworkopen.2025.9442. pii: .
Combining PSMA-Targeted Radiopharmaceutical Therapy with Immunotherapy. Altunay Betül, Schäfer Laura, Morgenroth Agnieszka, Peña Quim, Lammers Twan, Saar Matthias, Mottaghy Felix M, Lütje Susanne Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2025 Oct; 66(Oct):1522-1527. doi: 10.2967/jnumed.125.270317. pii: .
Current and future perspectives on radioligand therapy in advanced prostate cancer. Ahmed Buraq, Ravi Praful Therapeutic advances in medical oncology. 2026 ; 18():17588359251409047. doi: 10.1177/17588359251409047. pii: 17588359251409047.
Emerging PET Imaging Agents and Targeted Radioligand Therapy: A Review of Clinical Applications and Trials. Palihati Maierdan, Das Jeeban Paul, Yeh Randy, Capaccione Kathleen Tomography (Ann Arbor, Mich.). 2025 Jul; 11(Jul):doi: 10.3390/tomography11080083. pii: 83.
Exploring the role of combined external beam radiotherapy and targeted radioligand therapy with [177Lu]Lu-PSMA-617 for prostate cancer - from bench to bedside. Arbuznikova Daria, Klotsotyra Aikaterini, Uhlmann Lisa, Domogalla Lisa-Charlotte, Steinacker Nils, Mix Michael, Niedermann Gabriele, Spohn Simon K B, Freitag Martin T, Grosu Anca L, Meyer Philipp T, Gratzke Christian, Eder Matthias, Zamboglou Constantinos, Eder Ann-Christin Theranostics. 2024 ; 14():2560-2572. doi: 10.7150/thno.93249. pii: .
Novel radionuclide therapy combinations in prostate cancer. Inderjeeth Andrisha-Jade, Iravani Amir, Subramaniam Shalini, Conduit Ciara, Sandhu Shahneen Therapeutic advances in medical oncology. 2023 ; 15():17588359231187202. doi: 10.1177/17588359231187202. pii: 17588359231187202.
PSMA-based Therapies and Novel Therapies in Advanced Prostate Cancer: The Now and the Future. Ayzman Ann, Pachynski Russell K, Reimers Melissa A Current treatment options in oncology. 2025 May; 26(May):375-384. doi: 10.1007/s11864-025-01317-5. pii: .
Prostate Cancer Radioligand Therapy: PSMA and Beyond, Current Landscape and Future Directions. Bent Eric H, Morris Michael J Current oncology reports. 2025 Oct; 27(Oct):1170-1184. doi: 10.1007/s11912-025-01686-y. pii: .
Prostate-Specific Membrane Antigen-Ligand Therapy: What the Radiologist Needs to Know. Rowe Steven P, Sadaghiani Mohammad S, Gafita Andrei, Sheikhbahaei Sara, Pomper Martin G, Young Jeffrey, Spitz Avery, Werner Rudolf A, Oldan Jorge D, Solnes Lilja B Radiologic clinics of North America. 2024 Jan; 62(Jan):177-187. doi: 10.1016/j.rcl.2023.07.003. pii: S0033-8389(23)00163-X.
Review of radiopharmaceutical therapy in prostate cancer. Miller Sean R, Dewaraja Yuni, Rowe Steven P, Reichert Zachery R, Viglianti Benjamin L Urologic oncology. 2026 Feb; 111030. doi: 10.1016/j.urolonc.2026.111030. pii: S1078-1439(26)00041-4.
Nenhuma revista foi definida para este congresso.